137 related articles for article (PubMed ID: 26837447)
1. Renal Amyloidosis.
Mohamed N; Nasr SH
Surg Pathol Clin; 2014 Sep; 7(3):409-25. PubMed ID: 26837447
[TBL] [Abstract][Full Text] [Related]
2. Amyloidosis-associated kidney disease.
Dember LM
J Am Soc Nephrol; 2006 Dec; 17(12):3458-71. PubMed ID: 17093068
[TBL] [Abstract][Full Text] [Related]
3. A Novel Method of DAPI Staining for Differential Diagnosis of Renal Amyloidosis.
Matsuura M; Abe H; Tominaga T; Sakurai A; Murakami T; Kishi S; Bando Y; Minakuchi J; Nagai K; Doi T
J Med Invest; 2017; 64(3.4):217-221. PubMed ID: 28954985
[TBL] [Abstract][Full Text] [Related]
4. Renal amyloidosis: a new time for a complete diagnosis.
Feitosa VA; Neves PDMM; Jorge LB; Noronha IL; Onuchic LF
Braz J Med Biol Res; 2022; 55():e12284. PubMed ID: 36197414
[TBL] [Abstract][Full Text] [Related]
5. [Systemic AA amyloidosis induced by benign neoplasms].
Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
[TBL] [Abstract][Full Text] [Related]
6. Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis.
Dasari S; Amin MS; Kurtin PJ; Vrana JA; Theis JD; Grogg KL; Alexander MP; Nasr SH; Fervenza FC; Leung N; Sethi S
Kidney Int; 2016 Sep; 90(3):658-64. PubMed ID: 27262366
[TBL] [Abstract][Full Text] [Related]
7. Renal amyloidosis: an update on diagnosis and pathogenesis.
Gupta N; Kaur H; Wajid S
Protoplasma; 2020 Sep; 257(5):1259-1276. PubMed ID: 32447467
[TBL] [Abstract][Full Text] [Related]
8. The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry.
Gonzalez Suarez ML; Zhang P; Nasr SH; Sathick IJ; Kittanamongkolchai W; Kurtin PJ; Alexander MP; Cornell LD; Fidler ME; Grande JP; Herrera Hernandez LP; Said SM; Sethi S; Dispenzieri A; Gertz MA; Leung N
Kidney Int; 2019 Oct; 96(4):1005-1009. PubMed ID: 31447055
[TBL] [Abstract][Full Text] [Related]
9. Optimal conditions and the advantages of using laser microdissection and liquid chromatography tandem mass spectrometry for diagnosing renal amyloidosis.
Aoki M; Kang D; Katayama A; Kuwahara N; Nagasaka S; Endo Y; Terasaki M; Kunugi S; Terasaki Y; Shimizu A
Clin Exp Nephrol; 2018 Aug; 22(4):871-880. PubMed ID: 29372474
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining.
Paueksakon P; Fogo AB; Sethi S
Hum Pathol; 2014 Jul; 45(7):1445-50. PubMed ID: 24792621
[TBL] [Abstract][Full Text] [Related]
11. The Prevalence and Management of Systemic Amyloidosis in Western Countries.
Nienhuis HL; Bijzet J; Hazenberg BP
Kidney Dis (Basel); 2016 Apr; 2(1):10-9. PubMed ID: 27536687
[TBL] [Abstract][Full Text] [Related]
12. A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue.
Gilbertson JA; Theis JD; Vrana JA; Lachmann H; Wechalekar A; Whelan C; Hawkins PN; Dogan A; Gillmore JD
J Clin Pathol; 2015 Apr; 68(4):314-7. PubMed ID: 25637636
[TBL] [Abstract][Full Text] [Related]
13. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
[TBL] [Abstract][Full Text] [Related]
14. [Renal amyloidosis].
Kościelska M; Shebani Z; Matuszkiewicz-Rowińska J
Przegl Lek; 2013; 70(4):205-10. PubMed ID: 23991559
[TBL] [Abstract][Full Text] [Related]
15. [Amyloid typing from formalin-fixed paraffin-embedded tissues using LMD-LC-MS/MS system].
Tasaki M; Obayashi K; Ueda M; Ando Y
Rinsho Byori; 2014 Mar; 62(3):291-6. PubMed ID: 24800507
[TBL] [Abstract][Full Text] [Related]
16. [Proteomics, a new tool for an accurate typing of amyloidosis].
Colombat M; Holifanjaniaina S; Onifarasoaniaina S; Valleix S; Maisonneuve H; Kahn JE;
Rev Med Interne; 2015 May; 36(5):346-51. PubMed ID: 25544147
[TBL] [Abstract][Full Text] [Related]
17. The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.
Nasr SH; Said SM; Valeri AM; Sethi S; Fidler ME; Cornell LD; Gertz MA; Dispenzieri A; Buadi FK; Vrana JA; Theis JD; Dogan A; Leung N
Kidney Int; 2013 Mar; 83(3):463-70. PubMed ID: 23302715
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
Picken MM
Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
[TBL] [Abstract][Full Text] [Related]
19. Amyloidosis: A cancer-derived paraproteinemia and kidney involvement.
Małyszko J; Kozłowska K; Małyszko JS
Adv Med Sci; 2017 Mar; 62(1):31-38. PubMed ID: 28153807
[TBL] [Abstract][Full Text] [Related]
20. Confirming the Diagnosis of Amyloidosis.
Wisniowski B; Wechalekar A
Acta Haematol; 2020; 143(4):312-321. PubMed ID: 32544917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
